Announcement PDF BPH Global Ltd | ASX: BP8 | Date: 12 May 2026 BPH Global Ltd | www.bphglobal.com Agreement to Develop Powdered Green Seaweed Kefir Additive for Nutraceutical Beverage Applications Highlights ● Agreement executed with Singapore Polytechnic’s Food Innovation & Resource Centre (FIRC). ● Focus on freeze-drying probiotic green seaweed kefir into a powdered format. ● Development of a powdered kefir additive designed to deliver seaweed-derived nutraceutical benefits in consumable beverages. ● Objective to validate proof-of-concept (POC) for commercial powder applications. ● Powder format targets long shelf life, transport efficiency, and scalability. ● Strategy to supply powder to bottled water, alcoholic and non-alcoholic beverage manufacturers. ● Powder also has potential applications in food products, expanding future commercial pathways. ● Discussions underway with potential commercial partners. The Board of BPH Global Ltd (ASX: BP8) (BP8, BPH Global or Company) a leading commercial seaweed supply and export Company, is pleased to pleased to announce its wholly owned Singapore subsidiary, Stemcell United Pte Ltd, has entered into an agreement with Singapore Polytechnic’s Food Innovation & Resource Centre (FIRC) to support the development of a powdered green seaweed kefir product. The engagement builds on the Company’s recently completed R&D program with Singapore Polytechnic, which successfully developed probiotic and postbiotic green seaweed kefir beverages. This new phase focuses specifically on the Company’s proprietary probiotic formulation and aims to evaluate the feasibility of converting the fermented liquid into a freeze-dried powder format. The project is centred on developing a powdered kefir additive that can be incorporated into consumable beverages, enabling manufacturers to deliver the nutritional and functional benefits of fermented seaweed-derived nutraceuticals in a convenient, scalable format. This approach represents a shift from finished beverage products toward a ingredient-based commercial model. Under the agreement, FIRC will provide technical services to support process development and validation, including fermentation, microbiological assessment, and freeze-drying of the kefir product. BPH Global Ltd | ASX: BP8 | Date: 12 May 2026 BPH Global Ltd | www.bphglobal.com Commercial Strategy Unlike the liquid probiotic beverage, the powdered format is intended to be positioned as a functional ingredient for use across a range of beverage applications. Subject to successful validation, the Company intends to market the powder to manufacturers in the bottled water, alcoholic, and non-alcoholic beverage sectors, where it can be incorporated into existing product lines to enhance nutritional value. In addition to beverage applications, the powder may also be incorporated into food products, providing further potential commercial pathways. However, the Company’s immediate focus remains on beverage-based applications, where integration and scalability are more readily achievable. The Company is currently in preliminary discussions with potential venture and commercial partners to support downstream manufacturing and distribution. Next Steps • Completion of freeze-drying trials and process optimisation. • Validation of stability, dispersibility, and functional properties. • Assessment of scalability and manufacturing pathways. • Advancement of commercial partnership discussions. Managing Director Matthew Leonard said: “This agreement represents a strategic evolution toward an ingredient- based commercial model. By developing a powdered kefir additive, we are enabling beverage manufacturers to incorporate seaweed-derived nutraceutical benefits into their products in a scalable and commercially attractive way. This significantly broadens our addressable market beyond standalone beverages and positions the Company within the growing functional ingredients sector.” Summary of Material Terms ● Service commitment: FIRC will provide approximately 100 man hours of technical services to support process development. ● Services: include research, formulation, testing, and freeze-drying process development. ● Testing components: The project includes microbiological safety assessment and validation of the freeze-dried powder format. ● Term: The agreement has a 12-month term, during which the allocated man hours must be utilised. ● Total project cost: Approximately S$15,260 (including GST). ● IP: Intellectual property developed under the project is owned by the Company. BPH Global Ltd | ASX: BP8 | Date: 12 May 2026 BPH Global Ltd | www.bphglobal.com – ENDS – Authorised for release by: The Board of BPH Global Ltd Paul Stephenson Media and Investor Relations Chairman Peter Taylor BPH Global Ltd peter@nwrcommunications.com.au bphglobal.com.au